Scarica l'app Stockscreener
115.48
0.82%
0.94
Dopo l'orario di chiusura:
115.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$114.54
Aprire:
$113.91
Volume 24 ore:
1.11M
Relative Volume:
0.51
Capitalizzazione di mercato:
$32.63B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
25.46
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
+1.76%
1M Prestazione:
-2.28%
6M Prestazione:
-16.74%
1 anno Prestazione:
-0.44%
Intervallo 1D:
$112.99
$117.32
Intervallo di 1 settimana:
$109.90
$117.32
Portata 52W:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies (A) to acquire Biocare Medical for $950M - MSN
Laboratory Chromatograph: Core Tool in Analytical Science - AD HOC NEWS
Agilent Technologies, Inc. (A) stock price, news, quote and history - Yahoo Finance UK
A PE Ratio & Valuation, Is A Overvalued - Intellectia AI
Agilent Technologies Announces Executive Transition Agreement with Bret DiMarco – Key Terms and SEC Filing Details 11 - minichart.com.sg
Quintet Private Bank Europe S.A. Has $1.26 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $1.70 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Agilent Announces Transition Plan for Chief Legal Officer - TipRanks
Agilent Technologies, Inc. (A) Stock forecasts - Yahoo Finance UK
Agilent Technologies announces transition of chief legal officer Bret DiMarco By Investing.com - Investing.com Australia
Agilent Technologies (A) Announces Transition of Chief Legal Off - GuruFocus
How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch - finance.yahoo.com
Agilent Technologies announces transition of chief legal officer Bret DiMarco - Investing.com
Agilent (NYSE: A) details Chief Legal Officer transition and advisory role - Stock Titan
Agilent Technologies Adjusts Valuation Amid Strong Institutional Support and Financial Metrics - Markets Mojo
TRADE NEWS: Agilent Technologies Ships Newest EMPro Software Release for Analyzing 3-D Electromagnet - yahoo.com
Agilent Opens CEC in Mumbai to Strengthen India’s Scientific Ecosystem - Chemical Industry Digest
Louisbourg Investments Inc. Sells 12,946 Shares of Agilent Technologies, Inc. $A - MarketBeat
Is It Time To Revisit Agilent Technologies (A) After Recent Share Price Weakness - Sahm
Lab chromatographs are getting smarter: what Agilent is quietly changing for US labs - AD HOC NEWS
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Henson Meghan - Moomoo
Agilent (NYSE: A) SVP surrenders shares to cover RSU tax bill - Stock Titan
Agilent Technologies Reports Fourth-Quarter 2012 Results - yahoo.com
Agilent launches Cytation 9 cell imaging multimode reader By Investing.com - Investing.com South Africa
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader - BioSpace
Agilent's Local Strategy Cuts Supply Chain Risk, Drives India Growth - Whalesbook
Agilent Technologies “in country, for country” strategy helps mitigate supply disruptions - BusinessLine
Agilent Expands India’s Scientific Ecosystem with New Customer Experience Center in Mumbai - healthcareexecutive.in
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai - BioSpectrum India
A Stock Price, Quote & Chart | AGILENT TECHNOLOGIES INC (NYSE:A) - ChartMill
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo! Finance Canada
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents - PR Newswire
Agilent Technologies Announces Cash Dividend of 12 Cents per Share - yahoo.com
Agilent (A) Unveils Innovative BioTek Cytation 9 Cell Imaging Re - GuruFocus
Agilent Technologies Inc Announces the Biotek Cytation 9 Cell Imaging Multimode Reader - MarketScreener
Flow Cytometry Market Is Booming So Rapidly | Agilent Technologies Inc. • Danaher • Enzo Life Sciences Inc - openPR.com
Agilent launches Cytation 9 cell imaging multimode reader - Investing.com
Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P. - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Scharf Investments LLC - MarketBeat
Agilent Technologies Inc. stock rises Tuesday, still underperforms market - MarketWatch
SNP Genotyping and Analysis Market to See Booming Growth - openPR.com
J. Safra Sarasin Holding AG Sells 39,952 Shares of Agilent Technologies, Inc. $A - MarketBeat
Dissolution Online Systems Market Is Going to Boom | Agilent Technologies • Merck KGaA • PerkinElmer - openPR.com
Forecast Cut: Whats the beta of Agilent Technologies Inc stockMarket Weekly Review & Expert Verified Movement Alerts - baoquankhu1.vn
Agilent Technologies, Inc.: - MarketScreener
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies price faces negative outlookForecast today30-03-2026 - economies.com
Agilent Technologies' Advanced Chromatography Solutions: Driving Precision Analytics in North Americ - AD HOC NEWS
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):